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Nanobiotechnology is an emerging field that has recently been explored
for peripheral neural regeneration (PNR). Being a public-health problem,
peripheral nerve injuries (PNIs) should be treated by the therapiesthat
ensure swift functional recovery. The autologous nerve grafts (standard
treatment for PNIs) are rarely available and also cause morbidity and
neuroma formation at the harvest site, hence an alternative approach
with minimum complications is required for the treatment of serious PNIs.
Although nerve guidance conduits (NGCs) provide microenvironment for
axonal regeneration but they are as yet imperfect solutions. Nanoparticles
(e.g., metallic and metallic oxide nanoparticles) have properties which
are interesting to include in biomaterials developed for peripheral
nervous system regeneration including potential theranostic function.
It is important to get an insight into the fundamental mechanisms of
reconstruction of peripheral nerves for clinical translation of pre-clinical
outcomes of the use of nanoparticles in PNR. Moreover, the combination
of nanotechnological strategies is expected to provide transition from bed
to bench-side and beyond to the patients, clinicians, and researchers.
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Introduction

Nanotechnological approaches using nanomaterials (< 100 nm in size) are finding pace at
an incredible rate due to their applications in
different fields of life such as agriculture, medicine,
environment, cosmetics, electronics, etc. [1, 2].
The solid and colloidal forms of nanoparticles are
prepared having diverse properties. Nanoparticles
and the products of nanoscale technology such
as nanofibers are used in the field of tissue
engineering and regenerative medicine. The
Corresponding author: Rabia Javed, E-mail: rabia.javed@ymail.com

mechanical strength and biological activities of
nanoparticles make them interesting for inclusion
in biomaterials to be used in scaffolds for tissue
regeneration [3].
The defects of nervous system are among the
most common defects regarding different human
illnesses. About 13 to 23 in 100,000 persons are
affected each year by peripheral nerve injuries
(PNIs) [4]. Peripheral nerves have complex
anatomy and physiology. Their cell bodies are
present in spinal cord and long tubular axons
emerge from cell bodies and end in the organs
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or muscles. Every axon has three layers of
connective tissue; the outer layer covering
peripheral nerves is epineurium, the middle
layer around every fascicle is perineurium, and
the inner layer containing myelinated axon is
endoneurium. These layers are also crucial
for maintenance of nerve function after mild
trauma. The sensory and motor functions are
badly affected leading to adverse physical and
mental health of patients [5, 6]. Fortunately, the
peripheral nervous system (PNS) has intrinsic
ability of self-repair of small and large nerve fibers.
Glial cells or neuroglia are recognized as the key
cells involved in peripheral nerve regeneration
(PNR). Schwann cells (SCs) are the major glial
cells present in axons that are essential for the
survival of injured axons and regeneration of
PNS under critical situations [5].
The axonal transection causing the formation
of small gaps is auto-healed by the local
biomolecules which lead to spontaneous recovery
by means of direct anastomosis. However, the
larger gaps are repaired by the autologous
nerve grafts which is a gold standard treatment
in peripheral nerve therapeutics. However,
availability of donor nerves and donor site
morbidity are serious issues. Nevertheless,
autografting results in functional recovery by
removing immunogenicity issues and favoring
microstructural regeneration. Also, acellular nerve
allografts have been reported as an effective
therapeutic procedure for the repair of peripheral
nerves. Moreover, the nerve guidance conduits
have revealed promising outcomes regarding
PNR. Hitherto, the most impressive technology
is nanoparticle-based which enables the fabrication
and engineering of atomic and molecular scale
novel biomaterials [7].
Since the development of novel neuroregenerative approaches for PNR is very challenging,
nanotechnology-based therapies should be con-

sidered for reconstruction of peripheral nerves
by an incorporation of nanoparticles within the
scaffolds, and for the sustained and controlled
delivery of bioactive molecules at the site of
injury. They also provide more specificity and
rapid rate of regeneration because the roughness
of nanoparticles resembles that of extracellular
matrix (ECM) [8, 9]. In the field of bioengineering
and biotechnology of peripheral nerves, the
regeneration potential of nanoparticles or
nanostructured biomaterials have recently been
evaluated by many researchers. It has been proven that nanomaterials-based technologies have
enormous capability to remodel the biomimetic
environment for the repair of peripheral
nerves [10].
The general mechanism for peripheral nerve
reconstruction, traditional and recent treatments
for injured peripheral nerves with special emphasis
on emerging therapies, and the molecular
mechanism encompassing nanoparticles for the
repair of PNI have been described in the review
herein. The most important aspect of this article
is the description of properties of nanomaterials
that offer promise for theranostics of PNIs.

2

Mechanisms of PNR

The axons of peripheral nerves are damaged as
a result of PNIs caused by the physical means,
and then Wallerian degeneration begins within
24 to 36 h in the distal stump of axon. In order
to protect neuronal cell death, the SCs are
proliferated, macrophages are recruited, and the
axonal and myelin debris is eliminated from the
site of injury. After the migration of SCs, axonal
regeneration takes place by their outgrowth into
the special columns called bands of Bungner and
the SCs differentiate leading to remyelination. In
the way, the repair of peripheral nerves occur [7]
as illustrated in Fig. 1.
Journal of Neurorestoratology
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Fig. 1 Illustration of mechanisms of peripheral nerve regeneration.
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Conventional and modern treatments
for PNR

PNS if injured disables the patients suffering from
this trauma. Various micro-surgical technologies
are employed for the reconstruction of peripheral
nerves for the past few decades. Autologous nerve
grafting is performed in case of long distance
gaps (> 30 mm) but this technique also leads
to the sacrifice of healthy nerves [11]. The preparation of nerve guides imitating the structure
of ECM are the main focus of bioengineering
research. By providing favorable in vivo conditions,
ECM-based scaffolds are reported to promote
neural tissue regeneration [12]. Artificial nerve
grafts or nerve guidance conduits (NGCs) are the
alternatives to autologous nerve grafts and usually
possess nerve growth factors (NGFs) among other
neurotrophic factors and different biomaterials [13].
The structures of autologous nerve grafts and nerve
guidance conduits have been presented in Fig. 2.
Some of NGCs have been approved by the
Food and Drug Administration (FDA) and are
composed of materials like polyglycolic acid
(PGA), polylactic-co-glycolic acid (PLGA), poly-

caprolactone (PCL), and polyhydroxybutyrate
(PHB) [14, 15]. Different types of NGFs and
support cells with the variety of conduit materials
have been utilized for optimization of better
neural tubes [16]. Free NGFs have short half-life
due to enzymatic degradation in in vivo system
that also results in the loss of their biological
activity. However, the NGFs conjugated with
or encapsulated with the nanoparticles have
prolonged half-lives and more stability. Hence,

Fig. 2 Diagrammatic representation of nerve graft and
nerve conduit for PNR.
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they result in efficient reconstruction of axons and
promote myelin sheath formation around damaged
axons [17–20].
The physical properties required for the
material of NGCs include good permeability
and flexibility as well as appropriate rate of
degradation and swelling [21, 22]. Moreover,
NGCs should be highly biocompatible and
biodegradable to promote axon guidance and
maturation [23]. Nerve conduits have been
used in clinical practice for many years showing
significant improvements in patients after
surgery. For instance, nerve gaps of ≤ 30 mm
were effectively repaired and became functional
in patients with several PNIs as reported by Gu
et al. [24]. Fig. 3 describes different past, present,
and future treatment methods for PNR.

4

Emerging treatments for PNR

Nowadays nanoparticles have been employed
for the neural repair of peripheral injuries due
to their small size, surface functionalization,
unique physical properties, and chemical stability.
Different nanoparticles differ from one another
in terms of their electric charge, and optical and
magnetic characteristics [25]. Nanotechnologybased manipulations are simple, cost-effective,

and biocompatible. Nanomaterials have been
specifically employed in PNS due to their ability
to repair larger nerve gaps in case of severe
injuries [26]. The nanoconduits are the result of
advanced tissue engineering approach and have
produced remarkable results regarding the
promotion of outgrowth, regeneration, and survival
of peripheral nerves. The mechanical properties
and rate of degradation of nerve scaffolds also
improves by means of nanoparticles. Furthermore,
nanoparticles mimic the nanostructure and
microstructure of extracellular matrix (ECM) for
cellular attachment and nutrients transport [27].
In fact, the presence of nanoparticles in scaffolds
function in triggering their biological behavior,
making them behave as autograft nerves because
of their similarity to ECM on nanoscale [28]. The
nanoporous surface of scaffolds makes them
permeable for the efficacious supply of oxygen
and nutrients inside, and speedy removal of
toxic effluents outside, hence preventing the
inflammatory response. The nano-sized pores
have also been proven beneficial for facilitation of
axonal growth in longitudinal direction [10].
The nanoparticles-based regenerative therapy
for PNS should be completely functional and
effective unlike the traditional therapies that
result in only partial recovery. Therefore, the

Fig. 3 Flow chart showing conventional, modern, and emerging treatment strategies for PNR.
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stimuli-responsive smart biomaterials are tailored
and selective candidates are fabricated that
undergo necessary modifications on exposure to
temperature, pH, and electromagnetic field in
the development of novel and patient-oriented
therapies. The versatile and tunable physical and
biochemical properties of organic and inorganic
nanoparticles have been proved beneficial in the
modification of tumor microenvironment of PNS,
and most efficacious for the targeted and specified
delivery of biomolecules for the regeneration of
PNS [29]. The incorporation of nanoparticles
into intrinsic scaffolds has been reported to
promote nerve regeneration in animal models.
Still no clinical trial registration for nanoscaffolds
of PNIs has been reported according to the
clinicaltrials.gov platform and Cochrane Reviews
Database [7, 30, 31]. The nanoscaffolds are
composed of natural and synthetic materials;
electrospun silk fibroin nanofibers and carbon
nanotube (CNT) fibers are natural biomaterials,
while carbon nanomaterials, most importantly,
CNTs having graphene sheets are the best
representatives of synthetic biomaterials. Few
synthetic materials are non-biodegradable that
need to be removed after surgery. Ideal nanoscaffolds should be biodegradable, biocompatible,
having supreme mechanical integrity, and must
be capable of adhesion, migration, proliferation,
growth, and differentiation of SCs into the injured
neuron. They should also be able to synthesize
neurotrophins and other growth factors by
regulating the gene expression. Besides, they
must respond to electrical and magnetic signals
by significantly stimulating the PNR. Graphenes
have been reported to elicit functional recovery of
peripheral neurons, and magnetic nanoparticles
have shown good magnetization working well for
the enhancement of vitality of SCs by the increased
expression of BDNF, GDNF, NT-3, and VEGF
genes and elongation of axonal growth in dorsal
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root ganglion (DRG) cells. Rat sciatic nerve
defect model is the most commonly used animal
model to study cellular and molecular changes
occurring during PNR [31, 32]. The nanofibers
as well as organic and inorganic nanoparticles
have been shown efficacious in PNR in recent
years. Nanofibers fabricated from nanoparticles
by electrospinning technique are either random
or aligned as shown in Fig. 4, and have been
proven effective for PNR The inorganic
nanoparticles include gold (Au), silver (Ag),
silica (SiO2), and magnetic (most importantly
Fe3O4) nanoparticles. Chitosan is a well-known
biopolymer that can be used to make chitosan
nanoparticles which are organic in nature [29].
Table 1 represents few examples of the significant
effects caused by different nanoparticles on
PNS for the recovery of PNIs. The results of
nanoparticle-based approaches have revealed
that the nanoscaffolds perform superior to the
scaffolds fabricated without nanoparticles due to
the smaller size and larger surface area of the
former. Moreover, the nanomaterials or nanoscaffolds possess tremendous ability to mimic the
peripheral nerves with respect to their structure
and function. Therefore, the appropriate design
and fabrication of nanoscaffolds using advanced
technologies is critical to the treatment of PNIs.
Electrospun

nanoscaffolds

have

produced

promising outcomes regarding in vitro and in
vivo studies performed so far at the preclinical
stages [30].

Fig. 4

Types of nanofibers. (A) Aligned nanofibers.

(B) Random nanofibers.
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Since the nanocomposite biomaterials have
shown outstanding results regarding in vivo
studies, these are mostly preferred for PNR. These
complex nanostructures prevent inflammation
and the nerves are effectively grown, repaired,
and neuroprotected using nanocomposites as
biomaterials. Usually different biomaterials like
nanoparticles, electrospun fibers, hydrogels, etc.
are combined to form hybrid structures for
the stimulation of mechanical stabilization and
promotion of efficacious functionalization [33].
Different stimulation strategies such as those
involving magnetic and electric field have been
employed for orientation of nanofibers that
promote nerve regeneration. The combined use
of magnetic nanoparticles and external magnetic
field enhances axon elongation and growth by
creating a tensive force for the therapy of injured
peripheral nerves. It has been speculated that
the FDA-approved magnetic nanoparticles
would soon be implanted by neurosurgeons at
the site of injury alongwith the employment of
electromagnetic fields for the guidance of PNR
[34, 35]. Moreover, it has also been reported that
the higher concentration of nanoparticles can
cause oxidative stress and production of reactive
oxygen species (ROS) that leads to inflammation
of intracellular pathways. Moreover, DNA and
cellular damage also results in cancer and other
diseases [36, 37].

5

Molecular mechanism of PNR using
nanoparticles

The extracellular signal-regulated kinase (ERK)
belongs to the mitogen-activated protein kinase
(MAPK) family. ERK/MAPK signaling pathway
is activated for the regulation of regeneration of
peripheral nerves. The serine or threonine kinases,
the ERK1 and ERK2, are triggered in response to
external stimuli. Another pathway is Raf signaling
that is involved in boosting up of demyelination

of neuron and causing inflammation. The
inhibition of this pathway promotes PNR. The
in vitro studies on CNTs and magnetite nanoparticles in the form of nanoscaffolds have been
documented to evoke ERK pathway. It is believed
that miRNAs are involved in regulating the
gene expression of proteins of ERK pathway
and reported to promote the growth and axonal
guidance of PC12 and DRG cells [32, 48].

6

Conclusions and prospect

PNIs is a worldwide problem that needs to be
properly managed by clinicians and researchers.
PNIs cause deterioration of peripheral nerves by
the transection of axons, altering the quality of
patient’s life in a negative manner. Advanced
clinical treatments are required for restoration of
damaged peripheral nerves and for protecting
patients from being disabled for the lifetime.
Since the traditional methods of PNR are
unsatisfactory because of several limitations like
immune rejection and non-targeted delivery, novel
smart biomaterials are clinically demanded for
cell proliferation, migration, and cell to material
interaction for the repair of critical-sized defects.
Nanotechnology has tremendous potential to
treat neural disorders and nanoparticles are
already been utilized for this purpose due to their
unique and extraordinary properties. Nevertheless,
the long-term effects of nanoparticles on the
intracellular signaling pathways of neural cell
proliferation and differentiation as well as
inflammation needs to be deeply investigated.
Also, the real time imaging and personalized
treatment of PNIs is feasible using nanomedicine.
Novel nerve conduits having biodegradable
nanomaterials seems very promising. Since the
conventional scaffolds lack unique biochemical
and biophysical properties possessed by the
biomimetic nanoscale designs, the imbalanced
growth and nutritional microenvironment cannot
Journal of Neurorestoratology
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be remodeled by them. Hence, such novel
strategies should be devised that could incorporate
nanomaterial-based scaffolds in PNS for effective
repair of severely injured peripheral nerves. In
addition, three-dimensional structure of nanoparticle scaffolds should be imbedded with SCs
derived from autologous stem cells to avoid
immune rejection. As no clinical trial for the repair
of peripheral nerves mediated by nanoparticles
has been reported uptil now, therefore, more
research is required to be performed on the
fabrication and design of optimized multifunctional nanoscaffolds having properties that
could provide effectivity to the regeneration of
peripheral nerves of clinical models.
All obstacles and constraints to the development
of innovative methods for PNR should be
addressed by the state-of-the-art nanotechnologies.
As of now, the application of nanobiotechnology
in the field of tissue engineering PNS is taking
its first steps, hence many other aspects such as
nanotoxicology are likely to be considered for
the safe use of nanomaterials in neurobioengineering. For instance, an issue of cytotoxicity
resulting in excessive generation of ROS in
neuron cells poses hurdle to the clinical translation
of functional nanomaterials or related scaffolds
fabricated for the regeneration of PNS.
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